Product image of Monopril Plus (Fosinopril Sodium, Hydrochlorothiazide) supplied by GNH India

Monopril Plus

Active Ingredient:
Fosinopril Sodium, Hydrochlorothiazide
Origin:
EU

Monopril Plus (Fosinopril Sodium, Hydrochlorothiazide)

Fosinopril sodium / hydrochlorothiazide, the active ingredients in Monopril Plus, are an ACE inhibitor combined with a thiazide diuretic presented as a tablet for oral use. They are indicated for the management of hypertension in adult patients.

GNH India supplies Monopril Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Bausch Health Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Monopril Plus, an ACE inhibitor combined with a thiazide diuretic, is used to treat conditions related to elevated blood pressure.

  • Hypertension: lowers systolic and diastolic pressure in adults with primary hypertension.
  • Edema associated with hypertension: promotes fluid excretion to reduce swelling.
  • Hypertension in patients with type 2 diabetes: helps achieve target blood pressure while addressing sodium retention.

How It Works

  • Fosinopril sodium blocks the angiotensin‑converting enzyme, decreasing formation of angiotensin II and reducing vasoconstriction and aldosterone release. Hydrochlorothiazide inhibits sodium‑chloride reabsorption in the distal convoluted tubule, increasing urinary excretion of water and electrolytes. The combined actions lower peripheral vascular resistance and plasma volume, resulting in reduced blood pressure.

Side Effects

Common Side Effects

  • Cough: dry, persistent throat irritation.
  • Dizziness or light‑headedness, especially after standing.
  • Headache: mild to moderate intensity.
  • Increased urination: due to diuretic effect.
  • Electrolyte disturbances: such as low potassium.
  • Fatigue: general feeling of tiredness.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips, tongue, or airway.
  • Severe hypotension: marked drop in blood pressure causing fainting.
  • Acute kidney injury: sudden decline in renal function.
  • Hyperkalemia: elevated potassium levels.
  • Pancreatitis: inflammation of the pancreas.

Precautions & Warnings

Before initiating therapy, clinicians should assess patient suitability and monitor relevant parameters.

  • Blood pressure monitoring: ensure adequate control without excessive drop.
  • Renal function assessment: check serum creatinine and eGFR regularly.
  • Electrolyte surveillance: watch for potassium and sodium abnormalities.
  • Pregnancy safety: avoid use in pregnancy (Category D) due to fetal risk.
  • Discontinuation caution: do not stop abruptly; taper under medical supervision.
  • Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Monopril Plus may interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Aliskiren: combined use can cause renal impairment and hyperkalemia.
  • Potassium‑sparing diuretics or supplements: increase risk of dangerous hyperkalemia.
  • NSAIDs: may blunt antihypertensive effect and worsen renal function.
  • Lithium: ACE inhibition can raise lithium levels, risking toxicity.
  • Dual ACE inhibitor/ARB therapy: excessive renin‑angiotensin blockade.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: additive diuretic effect may cause volume depletion.
  • Other antihypertensives: may enhance blood pressure lowering, requiring dose adjustment.
  • Beta‑blockers: combined effect on heart rate and blood pressure.
  • Calcium channel blockers: possible additive hypotensive effect.
  • Antidiabetic agents: blood glucose may improve, necessitating dose review.

Frequently Asked Questions

Monopril Plus is a prescription medication that combines fosinopril sodium, an ACE inhibitor, with hydrochlorothiazide, a thiazide diuretic. The combination is used to lower high blood pressure in adult patients, helping to reduce the risk of cardiovascular events associated with hypertension.

Fosinopril sodium blocks the angiotensin‑converting enzyme, which prevents the conversion of angiotensin I to angiotensin II. This leads to vasodilation, reduced aldosterone secretion, and lower peripheral resistance, contributing to a decrease in blood pressure.

The dose of Monopril Plus is individualized by the prescribing healthcare professional based on the patient’s blood pressure, renal function, and response to therapy. Patients should follow the exact dosage instructions provided by their prescriber.

Monopril Plus is classified as Pregnancy Category D, indicating evidence of risk to the fetus. It should be avoided during pregnancy. Limited data are available for breastfeeding; the decision to use it while nursing should be made by a physician after weighing benefits and risks.

To order Monopril Plus, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Monopril Plus offers the dual benefit of an ACE inhibitor and a thiazide diuretic in a single tablet, which can simplify regimens compared with taking two separate drugs. Compared with other ACE‑inhibitor/diuretic combos, its efficacy and safety profile are similar, but individual patient factors determine the best choice.

Monopril Plus tablets should be stored at room temperature, below 25 °C, in the original packaging. Keep them away from moisture, heat, and direct sunlight to maintain product stability.

Monopril Plus is taken orally, usually once daily, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew unless instructed otherwise.

Serious risks include angioedema (swelling of the face, lips, tongue, or airway), severe hypotension, acute kidney injury, and hyperkalemia. Patients should seek immediate medical attention if they experience swelling, sudden dizziness, reduced urine output, or muscle weakness.

Monopril Plus should not be used by individuals with a known hypersensitivity to fosinopril, hydrochlorothiazide, or any component of the formulation. It is also contraindicated in patients with hereditary angioedema, severe renal impairment, or during pregnancy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.